BetaKine TGF-beta-2: Began a 90-patient Phase II study

Celtrix Pharmaceuticals Inc. (CTRX) Product: BetaKine TGF-beta-2 Indication: Slow or halt the progression of "wet" or exudative age-related macular degeneration Status: Began a 90-patient Phase II stu...